ArticleCancers2019

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes.

Isabella Faraoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.